Unknown

Dataset Information

Elucidating the cellular response of silver nanoparticles as a potential combinatorial agent for cisplatin chemotherapy.


ABSTRACT:

Background

Combination chemotherapy uses drugs that target different cancer hallmarks, resulting in synergistic or additive toxicity. This strategy enhances therapeutic efficacy as well as minimizes drug resistance and side effects. In this study, we investigated whether silver nanoparticles act as a combinatorial partner to cisplatin. In so doing, we compared post-exposure biological endpoints, intracellular drug accumulation, and changes in the proteome profile of tumoral and normal cell lines.

Results

Combinatorial exposure corresponded to cytotoxicity and oxidative stress in both cell lines, yet was substantially more effective against tumoral cells. Proteome analysis revealed that proteins related to energy metabolism pathways were upregulated in both cell lines, sugges

SUBMITTER: Rank Miranda R 

PROVIDER: S-EPMC7654574 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature